Skip to content

Profluent vs Recursion

A side-by-side comparison of Profluent and Recursion, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

Profluent

Science

Generative protein language models that design novel proteins.

View Profluent

Recursion

Science

AI-driven drug discovery on the Recursion OS platform.

View Recursion

At a glance

Feature comparison of Profluent and Recursion
AttributeProfluentRecursion
CategoryScienceScience
PricingPAIDPAID
LicenseProprietaryProprietary
DeploymentCloudCloud
PlatformsWebWeb
Model support (differs)—Self-contained (on-device)
Vendor (differs)Profluent BioRecursion Pharmaceuticals

The honest brief

Profluent

Pairs frontier protein LLMs with openly released designs like OpenCRISPR-1, while most peers keep AI-designed molecules proprietary.

  • ProGen protein-LLM lineage
  • Open-released gene editor
  • Nature-published work
  • Eli Lilly and IDT partnerships
  • Partnership/licensing only
  • No self-serve platform
  • Open releases are sequences, not a service
  • Opaque pricing

Recursion

Runs a vast in-house automated wet lab generating millions of cell experiments weekly, feeding a 50+ petabyte dataset few rivals can match.

  • Recursion OS with LOWE language layer
  • Massive proprietary biology dataset
  • Natural-language target and compound queries
  • Public company with pharma partners
  • No self-serve product or API
  • Partner and internal use only
  • Opaque pricing
  • No approved drug yet
Profluent detailsRecursion detailsAll Science apps